ReviewInternational journal of nanomedicine2025
Antimicrobial Mechanisms of Metal-Based Nanomaterials.
Review in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Remedial applications of biosynthesized metal oxide nanoparticles against pathogenic microorganisms.Discover nano · 2026Review
- Antifungal efficacy of a novel type of nanosalt against human fungal pathogens and its antifungal mechanisms.Applied microbiology and biotechnology · 2026Article
- Multifunctional YJournal of functional biomaterials · 2026Article
- Effect of CuO on the Structural, Antimicrobial, and Redox Activity of TiOGels (Basel, Switzerland) · 2026Article
- Ru Nanoparticles Ligated by an N-Heterocyclic Carbene Derived from Uracil Nucleoside as Selective Antimicrobial Agents.Inorganic chemistry · 2026Article
- Antibacterial and Bioregenerative Nanomaterials in Oral Health: From Material Design to Clinical Translation and Technological Trends.Journal of functional biomaterials · 2026Review
- Mechanisms ofMedicina (Kaunas, Lithuania) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the progress of nanotechnology and nano-medicine, a wide range of antimicrobial agents based on nanomaterials have been extensively developed and applied in anti-infection therapy. Metal-based nanomaterials, due to their unique physicochemical properties and outstanding biocompatibility, are extensively used in bioanalysis, drug delivery systems, disease diagnosis, and treatment. Compared with traditional antimicrobial agents, metal-based nanomaterials demonstrate advantages including superior stability, broad-spectrum antibacterial activity, potent antimicrobial effects, and lower risk of antibiotic resistance, making them a promising candidate for combating infections and drug-resistant bacteria. This article elucidates the antimicrobial mechanisms of metal-based nanomaterials, such as Au, Ag, Cu, ZnO, primarily focusing on physical damage, chemical activity, and biological function interference. Furthermore, it discusses synergistic antibacterial strategies to provide robust support for advancing research on the antimicrobial applications of metal-based nanomaterials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.